. . . . . . . . . . . . . . . . "cat(p(MGI:Tlr6)) -> p(MGI:Cd40)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Further studies demonstrated that MALP-2 treatment of DC results in a dose-dependent shift from the protein pattern of proteasomes to immunoproteasomes (up-regulation of LMP2, LMP7 and MECL1), which correlates with an increased proteolytic activity." . . "Selventa" . . . . "2014-07-03T14:32:17.437+02:00"^^ . . .